AN2 Therapeutics, Inc. Made Headway

Fri, Mar 06, 2026 at 07:26 PM

AN2 Therapeutics, Inc. (ANTX:NASDAQ) shot up at $2.85, a gain of 66.7%. On Fri, Mar 06, 2026, ANTX:NASDAQ hit a New 2-Week High of $2.85. The stock appeared on our News Catalysts scanner on Tue, Mar 03, 2026 at 05:13 PM in the 'BIOTECH' category. From Fri, Feb 20, 2026, the stock recorded 60.00% Up Days and 54.55% Green Days

About AN2 Therapeutics, Inc. (ANTX:NASDAQ)

AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs.

Top 10 Gainers:

Peraso Inc. (PRSO:NASDAQ), 151.54%
Decent Holding Inc. (DXST:NASDAQ), 83.61%
Edesa Biotech, Inc. (EDSA:NASDAQ), 80.61%
AN2 Therapeutics, Inc. (ANTX:NASDAQ), 66.67%
Day One Biopharmaceuticals, Inc. (DAWN:NASDAQ), 65.88%
Cre8 Enterprise Limited (CRE:NASDAQ), 65.33%
Epsium Enterprise Limited (EPSM:NASDAQ), 64.15%
Silynxcom Ltd. (SYNX:NYSEMKT), 57.99%
N2OFF, Inc. (NITO:NASDAQ), 38.64%
Cohen & Company Inc. (COHN:NYSEMKT), 36.23%